NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Coronado Biosciences Inc


Results 1 - 4


Refine Search
Display Mode: Context | Summary
Study Shows Coronado Biosciences' Bcl-2 Inhibitor, Apogossypol, is More Efficacious, Less Toxic than Gossypol in Animal Models
2008 FEB 11 ... Coronado Biosciences Inc. announced the publication of data demonstrating that the Bcl-2 inhibitor, Apogossypol, ...
Subject: Cancer
Price: $3.00
*
Study Shows Coronado Biosciences' Bcl-2 Inhibitor, Apogossypol, is More Efficacious, Less Toxic than Gossypol in Animal Models
2008 FEB 11 ... Coronado Biosciences Inc. announced the publication of data demonstrating that the Bcl-2 inhibitor, Apogossypol, ...
Subject: Cancer
Price: $3.00
*
Coronado Initiates Phase I Clinical Trial of Rationally Designed Fourth Generation Doxorubicin Analogue
2008 JAN 14 ... Coronado Biosciences Inc. announced that the first patient has been treated in a Phase I clinical trial of ...
Subject: Cancer
Price: $3.00
*
Coronado Builds Core Management Team
2008 JAN 14 ... Coronado Biosciences Inc. announced the appointments of Elizabeth Moore as senior vice president, regulatory ...
Subject: Clinical Trial Research
Price: $3.00
*

Results 1 - 4




-----------------------
PR Login